Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction.

Liu D, Hu K, Liebner E, Weidemann F, Herrmann S, Ertl G, Frantz S, Nordbeck P.

Int J Cardiovasc Imaging. 2018 Jul 23. doi: 10.1007/s10554-018-1416-z. [Epub ahead of print]

PMID:
30039338
2.

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease.

Liu D, Oder D, Salinger T, Hu K, Müntze J, Weidemann F, Herrmann S, Ertl G, Wanner C, Frantz S, Störk S, Nordbeck P.

Open Heart. 2018 Jul 12;5(2):e000803. doi: 10.1136/openhrt-2018-000803. eCollection 2018.

3.

European expert consensus statement on therapeutic goals in Fabry disease.

Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ.

Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. Review.

PMID:
30017653
4.

Group B Streptococci: Declining Incidence in Infants in Germany.

Wicker E, Lander F, Weidemann F, Hufnagel M, Berner R, Krause G.

Pediatr Infect Dis J. 2018 May 24. doi: 10.1097/INF.0000000000002115. [Epub ahead of print]

PMID:
29846301
5.

Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Liu D, Hu K, Schmidt M, Müntze J, Maniuc O, Gensler D, Oder D, Salinger T, Weidemann F, Ertl G, Frantz S, Wanner C, Nordbeck P.

Clin Res Cardiol. 2018 May 24. doi: 10.1007/s00392-018-1285-4. [Epub ahead of print]

PMID:
29797054
6.

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.

Oder D, Liu D, Üçeyler N, Sommer C, Hu K, Salinger T, Müntze J, Petritsch B, Ertl G, Wanner C, Nordbeck P, Weidemann F.

Medicine (Baltimore). 2018 May;97(21):e10669. doi: 10.1097/MD.0000000000010669.

7.

Fabry disease revisited: Management and treatment recommendations for adult patients.

Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, Eng C, Hopkin RJ, Laney D, Linhart A, Waldek S, Wallace E, Weidemann F, Wilcox WR.

Mol Genet Metab. 2018 Apr;123(4):416-427. doi: 10.1016/j.ymgme.2018.02.014. Epub 2018 Feb 28. Review.

8.

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Karch A, Mikolajczyk RT.

BMC Med. 2018 Jan 9;16(1):3. doi: 10.1186/s12916-017-0983-5.

9.

Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF.

Cowie MR, Woehrle H, Wegscheider K, Vettorazzi E, Lezius S, Koenig W, Weidemann F, Smith G, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H.

Eur J Heart Fail. 2018 Mar;20(3):536-544. doi: 10.1002/ejhf.1048. Epub 2017 Nov 30.

PMID:
29193576
10.

Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosages.

Krämer J, Lenders M, Canaan-Kühl S, Nordbeck P, Üçeyler N, Blaschke D, Duning T, Reiermann S, Stypmann J, Brand SM, Gottschling T, Störk S, Wanner C, Sommer C, Brand E, Weidemann F.

Nephrol Dial Transplant. 2017 Nov 23. doi: 10.1093/ndt/gfx319. [Epub ahead of print]

PMID:
29186537
11.

Analysing published global Ebola Virus Disease research using social network analysis.

Hagel C, Weidemann F, Gauch S, Edwards S, Tinnemann P.

PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005747. doi: 10.1371/journal.pntd.0005747. eCollection 2017 Oct.

12.

Extent of size, shape and systolic variability of the left ventricular outflow tract in aortic stenosis determined by phase-contrast MRI.

Sagmeister F, Weininger M, Herrmann S, Bernhardt P, Rasche V, Bauernschmitt R, Liebold A, Köstler H, Weidemann F, Beer M.

Magn Reson Imaging. 2018 Jan;45:58-65. doi: 10.1016/j.mri.2017.09.002. Epub 2017 Sep 5.

PMID:
28887207
13.

Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy.

Yogasundaram H, Kim D, Oudit O, Thompson RB, Weidemann F, Oudit GY.

Can J Cardiol. 2017 Jul;33(7):883-897. doi: 10.1016/j.cjca.2017.04.015. Epub 2017 May 4. Review.

PMID:
28668140
14.

Role of Global Longitudinal Strain in the Prediction of Outcome in Patients With Severe Aortic Valve Stenosis.

Fries B, Liu D, Gaudron P, Hu K, Nordbeck P, Ertl G, Weidemann F, Herrmann S.

Am J Cardiol. 2017 Aug 15;120(4):640-647. doi: 10.1016/j.amjcard.2017.05.032. Epub 2017 May 30.

PMID:
28648391
15.

Biomarkers for Diagnosing and Staging of Fabry Disease.

Kramer J, Weidemann F.

Curr Med Chem. 2018;25(13):1530-1537. doi: 10.2174/0929867324666170616102112.

PMID:
28618999
16.

Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.

Wilcox WR, Feldt-Rasmussen U, Martins AM, Ortiz A, Lemay RM, Jovanovic A, Germain DP, Varas C, Nicholls K, Weidemann F, Hopkin RJ.

JIMD Rep. 2018;38:45-51. doi: 10.1007/8904_2017_28. Epub 2017 May 17.

17.

Is the impact of childhood influenza vaccination less than expected: a transmission modelling study.

Weidemann F, Remschmidt C, Buda S, Buchholz U, Ultsch B, Wichmann O.

BMC Infect Dis. 2017 Apr 11;17(1):258. doi: 10.1186/s12879-017-2344-6.

18.

[The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome].

Oder D, Störk S, Wanner C, Ertl G, Weidemann F, Nordbeck P.

Dtsch Med Wochenschr. 2017 Mar;142(6):442-449. doi: 10.1055/s-0042-118303. Epub 2017 Mar 22. Review. German.

PMID:
28329906
19.

Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.

Liu D, Hu K, Herrmann S, Cikes M, Ertl G, Weidemann F, Störk S, Nordbeck P.

Int J Cardiovasc Imaging. 2017 Jun;33(6):837-845. doi: 10.1007/s10554-017-1075-5. Epub 2017 Mar 6.

20.

Patent Foramen Ovale and Cryptogenic Strokes in the Stroke in Young Fabry Patients Study.

Huber R, Grittner U, Weidemann F, Thijs V, Tanislav C, Enzinger C, Fazekas F, Wolf M, Hennerici MG, McCabe DJ, Putaala J, Tatlisumak T, Kessler C, von Sarnowski B, Martus P, Kolodny E, Norrving B, Rolfs A; Stroke in Young Fabry Patients (SIFAP) Investigators.

Stroke. 2017 Jan;48(1):30-35. doi: 10.1161/STROKEAHA.116.013620. Epub 2016 Nov 29.

PMID:
27899752
21.

Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation.

Hu K, Liu D, Störk S, Herrmann S, Oder D, Ertl G, Voelker W, Weidemann F, Nordbeck P.

J Card Fail. 2017 Jun;23(6):434-443. doi: 10.1016/j.cardfail.2016.11.005. Epub 2016 Nov 24.

22.

Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.

Üçeyler N, Schröter N, Kafke W, Kramer D, Wanner C, Weidemann F, Sommer C.

PLoS One. 2016 Nov 16;11(11):e0166484. doi: 10.1371/journal.pone.0166484. eCollection 2016.

23.

Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla.

Petritsch B, Köstler H, Weng AM, Horn M, Gassenmaier T, Kunz AS, Weidemann F, Wanner C, Bley TA, Beer M.

BMC Cardiovasc Disord. 2016 Oct 28;16(1):205.

24.

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.

Lenders M, Hennermann JB, Kurschat C, Rolfs A, Canaan-Kühl S, Sommer C, Üçeyler N, Kampmann C, Karabul N, Giese AK, Duning T, Stypmann J, Krämer J, Weidemann F, Brand SM, Wanner C, Brand E.

Orphanet J Rare Dis. 2016 Jun 29;11(1):88. doi: 10.1186/s13023-016-0473-4.

25.

Systematic Echocardiographic Evaluation of Mitral Valve Regurgitation for Transcatheter Edge-to-Edge Repair.

Wallenborn J, Herrmann S, Hansen M, Hu K, Voelker W, Störk S, Ertl G, Weidemann F.

Echocardiography. 2016 Jul;33(7):1069-79. doi: 10.1111/echo.13251. Epub 2016 Jun 27. Review.

PMID:
27350253
26.

Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.

Weidemann F, Maier SK, Störk S, Brunner T, Liu D, Hu K, Seydelmann N, Schneider A, Becher J, Canan-Kühl S, Blaschke D, Bijnens B, Ertl G, Wanner C, Nordbeck P.

Am J Cardiol. 2016 Jul 15;118(2):264-74. doi: 10.1016/j.amjcard.2016.04.033. Epub 2016 May 5.

27.

High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease.

Seydelmann N, Liu D, Krämer J, Drechsler C, Hu K, Nordbeck P, Schneider A, Störk S, Bijnens B, Ertl G, Wanner C, Weidemann F.

J Am Heart Assoc. 2016 May 31;5(6). pii: e002839. doi: 10.1161/JAHA.115.002839. Erratum in: J Am Heart Assoc. 2016;5(9). pii: e002114. doi: 10.1161/JAHA.116.002114.

28.

Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy.

Liu D, Hu K, Nordbeck P, Ertl G, Störk S, Weidemann F.

Eur J Med Res. 2016 May 10;21(1):21. doi: 10.1186/s40001-016-0216-y. Review.

29.

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.

Lenders M, Weidemann F, Kurschat C, Canaan-Kühl S, Duning T, Stypmann J, Schmitz B, Reiermann S, Krämer J, Blaschke D, Wanner C, Brand SM, Brand E.

Orphanet J Rare Dis. 2016 May 4;11(1):54. doi: 10.1186/s13023-016-0441-z.

30.

Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in Germany.

Christensen H, Irving T, Koch J, Trotter CL, Ultsch B, Weidemann F, Wichmann O, Hellenbrand W.

Vaccine. 2016 Jun 17;34(29):3412-9. doi: 10.1016/j.vaccine.2016.04.004. Epub 2016 Apr 22.

31.

Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip).

Wallenborn J, Störk S, Herrmann S, Kukuy O, Fette G, Puppe F, Gorski A, Hu K, Voelker W, Ertl G, Weidemann F.

Clin Res Cardiol. 2016 Aug;105(8):699-709. doi: 10.1007/s00392-016-0975-z. Epub 2016 Feb 26.

PMID:
26916650
32.

Long noncoding RNA Chast promotes cardiac remodeling.

Viereck J, Kumarswamy R, Foinquinos A, Xiao K, Avramopoulos P, Kunz M, Dittrich M, Maetzig T, Zimmer K, Remke J, Just A, Fendrich J, Scherf K, Bolesani E, Schambach A, Weidemann F, Zweigerdt R, de Windt LJ, Engelhardt S, Dandekar T, Batkai S, Thum T.

Sci Transl Med. 2016 Feb 17;8(326):326ra22. doi: 10.1126/scitranslmed.aaf1475.

PMID:
26888430
33.

The septal bulge--an early echocardiographic sign in hypertensive heart disease.

Gaudron PD, Liu D, Scholz F, Hu K, Florescu C, Herrmann S, Bijnens B, Ertl G, Störk S, Weidemann F.

J Am Soc Hypertens. 2016 Jan;10(1):70-80. doi: 10.1016/j.jash.2015.11.006. Epub 2015 Dec 2.

34.

Erratum: Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.

Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schäfer F, Wagner N, Ergün S, Schmitt JP, Katus HA, Weidemann F, Ravens U, Maack C, Hein L, Ertl G, Müller OJ, Maier LS, Lohse MJ, Lorenz K.

Nat Med. 2016 Feb;22(2):217. doi: 10.1038/nm0216-217c. No abstract available.

PMID:
26845407
35.

Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. Epub 2016 Feb 2.

36.

Thrombus-in-Transit Following Watchman Device Implantation.

Wallenborn J, Weidemann F, Lengenfelder B, Ritter O, Voelker W.

Echocardiography. 2016 May;33(5):788-791. doi: 10.1111/echo.13172. Epub 2016 Jan 27.

PMID:
26817966
37.

Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.

Krämer J, Bijnens B, Störk S, Ritter CO, Liu D, Ertl G, Wanner C, Weidemann F.

PLoS One. 2015 Nov 23;10(11):e0140627. doi: 10.1371/journal.pone.0140627. eCollection 2015.

38.

Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany.

Damm O, Horn J, Mikolajczyk R, Greiner W, Siedler A, Weidemann F, Wichmann O, Kretzschmar M, Ultsch B.

Value Health. 2015 Nov;18(7):A588. doi: 10.1016/j.jval.2015.09.1503. Epub 2015 Oct 20. No abstract available.

39.

Cost-Effectiveness of Pneumococcal Vaccination of Elderly In Germany.

Kuhlmann A, Treskova M, Ultsch B, Weidemann F, Wichmann O, Falkenhorst G, Graf von der Schulenburg J.

Value Health. 2015 Nov;18(7):A584. doi: 10.1016/j.jval.2015.09.1957. Epub 2015 Oct 20. No abstract available.

40.

Strain Analysis by Tissue Doppler Imaging: Comparison of Conventional Manual Measurement with a Semiautomated Approach.

Schmid J, Kaufmann R, Grübler MR, Verheyen N, Weidemann F, Binder JS.

Echocardiography. 2016 Mar;33(3):372-8. doi: 10.1111/echo.13100. Epub 2015 Oct 30.

PMID:
26515731
41.

Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry Cardiomyopathy.

Krämer J, Nordbeck P, Störk S, Ritter C, Ertl G, Wanner C, Weidemann F.

JIMD Rep. 2015 Oct 27. [Epub ahead of print]

42.

Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.

Schmid E, Neef S, Berlin C, Tomasovic A, Kahlert K, Nordbeck P, Deiss K, Denzinger S, Herrmann S, Wettwer E, Weidendorfer M, Becker D, Schäfer F, Wagner N, Ergün S, Schmitt JP, Katus HA, Weidemann F, Ravens U, Maack C, Hein L, Ertl G, Müller OJ, Maier LS, Lohse MJ, Lorenz K.

Nat Med. 2015 Nov;21(11):1298-306. doi: 10.1038/nm.3972. Epub 2015 Oct 19. Erratum in: Nat Med. 2016 Feb;22(2):217.

PMID:
26479924
43.

Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease.

Herrmann S, Fries B, Liu D, Hu K, Stoerk S, Voelker W, Ruppert C, Lorenz K, Ertl G, Weidemann F.

J Am Soc Echocardiogr. 2015 Nov;28(11):1270-1282.e4. doi: 10.1016/j.echo.2015.07.016. Epub 2015 Aug 28.

PMID:
26321001
44.

Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up.

Lenders M, Canaan-Kühl S, Krämer J, Duning T, Reiermann S, Sommer C, Stypmann J, Blaschke D, Üçeyler N, Hense HW, Brand SM, Wanner C, Weidemann F, Brand E.

J Am Soc Nephrol. 2016 Mar;27(3):952-62. doi: 10.1681/ASN.2015030337. Epub 2015 Jul 16.

45.

Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.

Hu K, Liu D, Nordbeck P, Cikes M, Störk S, Kramer B, Gaudron PD, Schneider A, Knop S, Ertl G, Bijnens B, Weidemann F, Herrmann S.

Int J Cardiovasc Imaging. 2015 Oct;31(7):1401-12. doi: 10.1007/s10554-015-0711-1. Epub 2015 Jul 16.

PMID:
26179863
46.

Long term evolution of magnetic resonance imaging characteristics in a case of atypical left lateral wall hypertrophic cardiomyopathy.

Gassenmaier T, Petritsch B, Kunz AS, Gkaniatsas S, Gaudron PD, Weidemann F, Nordbeck P, Beer M.

World J Cardiol. 2015 Jun 26;7(6):357-60. doi: 10.4330/wjc.v7.i6.357.

47.

The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement.

Weidemann F, Liu D, Hu K, Florescu C, Niemann M, Herrmann S, Kramer B, Klebe S, Doppler K, Üçeyler N, Ritter CO, Ertl G, Störk S.

Int J Cardiol. 2015 Sep 1;194:50-7. doi: 10.1016/j.ijcard.2015.05.074. Epub 2015 May 15.

48.

Fabry disease and the heart.

Seydelmann N, Wanner C, Störk S, Ertl G, Weidemann F.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):195-204. doi: 10.1016/j.beem.2014.10.003. Epub 2014 Oct 16. Review.

49.

Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.

Lorenzen JM, Schauerte C, Hübner A, Kölling M, Martino F, Scherf K, Batkai S, Zimmer K, Foinquinos A, Kaucsar T, Fiedler J, Kumarswamy R, Bang C, Hartmann D, Gupta SK, Kielstein J, Jungmann A, Katus HA, Weidemann F, Müller OJ, Haller H, Thum T.

Eur Heart J. 2015 Aug 21;36(32):2184-96. doi: 10.1093/eurheartj/ehv109. Epub 2015 Apr 21.

50.

Journey of a patient with chronic thromboembolic pulmonary hypertension.

Liu D, Hu K, Pelzer HT, Störk S, Weidemann F.

Eur J Med Res. 2015 Mar 2;20:20. doi: 10.1186/s40001-015-0112-x.

Supplemental Content

Loading ...
Support Center